Codes / ICD10CM / M1A.19

M1A.19 Lead-induced chronic gout, multiple sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Multiple Sites

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This condition involves persistent symptoms and may affect multiple joints, potentially resulting in tissue damage or tophi formation if untreated.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults
  • Impaired kidney function

Symptoms

  • Recurrent episodes of intense joint pain, often in the big toe, ankles, knees, or other affected sites
  • Persistent swelling, redness, and warmth in multiple joints
  • Formation of tophi (hard, painless lumps) under the skin
  • Stiffness and limited joint mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and confirms involvement of multiple sites.

Treatment Options

  • Medications such as non-steroidal anti-inflammatory drugs (NSAIDs) or colchicine for pain and inflammation
  • Urate-lowering therapies (e.g., allopurinol) to reduce crystal formation
  • Chelation therapy to address lead exposure
  • Lifestyle modifications to avoid triggers and reduce uric acid levels

Prognosis and Follow-Up

With proper treatment, symptoms can be managed, and further joint damage may be prevented. Regular follow-up is essential to monitor uric acid levels, adjust medications, and address any complications. Untreated cases may progress to chronic joint damage or tophi formation.

Complications

  • Chronic joint damage or deformity
  • Tophi formation in multiple sites
  • Kidney stones or renal impairment
  • Increased risk of cardiovascular disease

Lifestyle & Prevention

  • Avoid lead exposure through occupational or environmental sources
  • Maintain a balanced diet low in purines and alcohol
  • Stay hydrated to support uric acid excretion
  • Follow prescribed treatment plans consistently

When to Seek Professional Help

Seek medical attention if experiencing severe joint pain, swelling, or fever, or if symptoms worsen despite treatment. Prompt care can prevent complications and improve outcomes.

Tips for Medical Coders

Document the specific sites affected by gout to support the "multiple sites" designation. Ensure lead exposure is clearly documented as the underlying cause, and note any associated complications or treatment responses. Verify that the code aligns with clinical findings and documentation standards.

Book a walkthrough

M1A.19 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.